Browsing by Author "Simeunović, Dejan (14630934500)"
Now showing 1 - 5 of 5
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Correlation of atherogenic risk factors with retinal artery occlusion in adults; [Korelacija aterogenih faktora rizika s okluzijom retinalne arterije kod odraslih](2014) ;Risimić, Dijana (12773128400) ;Nikolić, Dejan (26023650800) ;Simeunović, Dejan (14630934500) ;Jakšić, Vesna (23667666000) ;Cekić, Sonja (36070315900)Milenković, Svetislav (55499350000)Aim To evaluate correlation of atherogenic risk factors between patients with retinal artery occlusion (RAO) and matched population, including those with central RAO and branch RAO. Methods Seventy-two participants from 2 groups were evaluated: a group with diagnosed RAO (first group; 45 participants) and a matched control group including those without RAO or any other ophthalmological disease (second group; 27 participants). From those with diagnosed RAO patients with central RAO and patients with branch RAO were evaluated separately. Additional parameters that were observed included body mass index (BMI), blood pressure, fasting glucose levels, triglycerides, LDL and HDL cholesterol fractions levels, presence of metabolic syndrome and hyperlipoproteinemia. Results There was a significant increase of LDL mean values in the group of patients with RAO. Hypertension (88.9%), hyperlipoproteinemia (68.9%) and metabolic syndrome (53.3%) were significantly more frequent in patients with RAO, while gender and diabetes mellitus were not in direct correlation with the development of RAO. The group of patients with RAO had no significantly higher values of BMI compared to the control. High density lipoprotein fraction was significantly higher in the group of patients with central RAO as compared with those with branch RAO. Conclusion Patients with atherogenic risk factors are more prone to the development of RAO. Furthermore, we demonstrated that HDL had more protective effects on smaller blood vessels (branch retinal artery) than on larger blood vessels (central retinal artery). - Some of the metrics are blocked by yourconsent settings
Publication Evaluation of body mass index and lipid fractions levels in patients with retinal artery occlusion; [Evaluacija indeksa telesne uhranjenosti i lipidnih frakcija kod bolesnika sa okluzijom retinalne arterije](2011) ;Risimić, Dijana (12773128400) ;Nikolić, Dejan (26023650800) ;Jakšic, Vesna (23667666000) ;Simeunović, Dejan (14630934500) ;Milenković, Svetislav (55499350000) ;Stefanović, Ivan (25628694100) ;Jaković, Nataša (55396741000) ;Milić, Nada (57196488815) ;Cekić, Sonja (36070315900)Babović, Siniša (57384231300)Background/Aim. There are studies stressing out that atherosclerosis is most common associated systemic condition in patients with retinal artery occlusion. The aim of this study was to analyze values of body mass index and lipid fractions in healthy individuals and patients with retinal artery occlusion. Methods. This study included 90 participants during a 6-year period. The population was divided into 2 groups: the group with the diagnosed retinal artery occlusion and the group without retinal artery occlusion. The observed parameters were as follows: body mass index, low and high density lipoproteins and triglycerides. Results. The study revealed no significant difference regarding body mass index and triglycerides values between the two evaluated groups, while low and high density lipoproteins values were significantly higher in the group of patients with retinal artery occlusion. Conclusions. The study demonstrated that body mass index and triglycerides have less important role in atherogenic pathogenesis of retinal artery occlusion, while low density lipoprotein is the fraction that is shown to be most potent in such etiological processes. - Some of the metrics are blocked by yourconsent settings
Publication Long-term mortality is increased in patients with undetected prediabetes and type-2 diabetes hospitalized for worsening heart failure and reduced ejection fraction(2019) ;Pavlović, Andrija (57204964008) ;Polovina, Marija (35273422300) ;Ristić, Arsen (7003835406) ;Seferović, Jelena P (23486982900) ;Veljić, Ivana (57203875022) ;Simeunović, Dejan (14630934500) ;Milinković, Ivan (51764040100) ;Krljanac, Gordana (8947929900) ;Ašanin, Milika (8603366900) ;Oštrić-Pavlović, Irena (55376449200)Seferović, Petar M (6603594879)Background: We assessed the prevalence of newly diagnosed prediabetes and type-2 diabetes mellitus (T2DM), and their impact on long-term mortality in patients hospitalized for worsening heart failure with reduced ejection fraction (HFrEF). Methods: We included patients hospitalized with HFrEF and New York Heart Association (NYHA) functional class II–III. Baseline two-hour oral glucose tolerance test was used to classify patients as normoglycaemic or having newly diagnosed prediabetes or T2DM. Outcomes included post-discharge all-cause and cardiovascular mortality during the median follow-up of 2.1 years. Results: At baseline, out of 150 patients (mean-age 57 ± 12 years; 88% male), prediabetes was diagnosed in 65 (43%) patients, and T2DM in 29 (19%) patients. These patients were older and more often with NYHA class III symptoms, but distribution of comorbidities was similar to normoglycaemic patients. Taking normoglycaemic patients as a reference, adjusted risk of all-cause mortality was significantly increased both in patients with prediabetes (hazard ratio, 2.6; 95% confidence interval (CI), 1.1–6.3; p = 0.040) and in patients with T2DM (hazard ratio, 5.3; 95% CI, 1.7–15.3; p = 0.023). Likewise, both prediabetes (hazard ratio, 2.9; 95% CI, 1.1–7.9; p = 0.041) and T2DM (hazard ratio, 9.7; 95% CI 2.9–36.7; p = 0.018) independently increased the risk of cardiovascular mortality compared with normoglycaemic individuals. There was no interaction between either prediabetes or T2DM and heart failure aetiology or gender on study outcomes (all interaction p-values > 0.05). Conclusions: Newly diagnosed prediabetes and T2DM are highly prevalent in patients hospitalized for worsening HFrEF and NYHA functional class II–III. Importantly, they impose independently increased long-term risk of higher all-cause and cardiovascular mortality. © The European Society of Cardiology 2018. - Some of the metrics are blocked by yourconsent settings
Publication Major Clinical Aspects of Diabetic Cardiomyopathy(2014) ;Mitrović, Jelena P. Seferović (56989068400) ;Seferović, Petar M. (6603594879) ;Ristić, Arsen D. (7003835406) ;Lalić, Katarina (13702563300) ;Jotić, Aleksandra (13702545200) ;Milinković, Ivan (51764040100) ;Simeunović, Dejan (14630934500)Lalić, Nebojša M. (13702597500)The cardiovascular complications of type 2 diabetes (T2DM) are contributing considerably to morbidity and mortality worldwide, heart failure (HF) being one of the most frequent. The adverse effect of T2DM on myocardium can develop early, and clinically present as left ventricular (LV) diastolic dysfunction in the absence of other heart disease. The pathophysiology of DC includes the major metabolic features of T2DM such as hyperglycemia, hyperinsulinemia, hyperlipidemia, and the formation of both reactive oxygen species and advanced glycation end-products. There are no pathognomonic diagnostic features of diabetic cardiomyopathy (DC) and no single imaging method exists for the accurate diagnosis. Clinical presentation is mostly mild, and majority of the patients are asymptomatic or with nonspecific complaints. The major hurdles in diagnosing DC are imprecise definition and dissimilar criteria for diagnosis of LV diastolic dysfunction. DC is best defined as myocardial disease in diabetic patients characterized by LV diastolic dysfunction in the absence of hypertension, coronary artery disease or any other cardiac disease. LV diastolic dysfunction is the most important element of diagnosis of DC, best assessed by tissue Doppler echocardiography (E/E' ratio). The prevalence of LV diastolic dysfunction in T2DM demonstrate the wide variations caused by diverse patient selection and heterogeneous criteria for its diagnosis. Patient selection varies in terms of age, duration, stage, and microvascular complications of T2DM. Several clinical correlates were reported as related to DC such as: age, duration of T2DM, parameters of glycoregulation, insulin resistance, and renal function. The treatment of DC should be initiated as early as LV diastolic dysfunction is identified. Various therapeutic options include improving diabetic control with diet, daily physical activity, and reduction in body mass index. Both antiglycaemic (metformin and thiazolidinediones), and cardiovascular drugs (ACE inhibitors, beta blockers and calcium channel blockers) should be used to improve LV diastolic dysfunction. © 2014 by Nova Science Publishers, Inc. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Management strategies in pericardial emergencies(2006) ;Seferović, Petar M. (6603594879) ;Ristić, Arsen D. (7003835406) ;Imazio, Massimo (55787131200) ;Maksimović, Ružica (55921156500) ;Simeunović, Dejan (14630934500) ;Trinchero, Rita (6701760573) ;Pankuweit, Sabine (7003360984)Maisch, Bernhard (36038356200)Background: The most frequent pericardial emergency is cardiac tamponade, but complications of an acute coronary syndrome and aortic dissection may also involve the pericardium. Acute pericarditis can also represent a medical emergency due to chest pain of upsetting intensity. Decompensations in chronic advanced constriction and in the clinical course of purulent pericarditis necessitate critical care as well. Diagnosis and Management: The diagnosis of cardiac tamponade is based on clinical presentation and physical findings, confirmed by echocardiography and cardiac catheterization. Tamponade is an absolute indication for urgent drainage, either by pericardiocentesis or surgical pericardiotomy. The approach for pericardiocentesis can be subxiphoid or intercostal using echocardiographic or fluoroscopic guidance. Urgent drainage, combined with intravenous antibiotics, is also mandatory in suspected purulent pericarditis. If confirmed, it should be combined with intrapericardial rinsing (best by a surgical drainage). Pericardiocentesis is contraindicated in cardiac tamponade complicating aortic dissection. This condition should immediately lead to cardiac surgery. Although pericardiectomy is the only treatment for permanent constriction, this procedure is contraindicated when extensive myocardial fibrosis and/or atrophy are demonstrated. Case Study: Iatrogenic tamponade may occur during percutaneous mitral valvuloplasty, implantation of pacemakers, electrophysiology and radiofrequency ablation procedures, right ventricular endomyocardial biopsy, percutaneous coronary interventions, and rarely during Swan-Ganz catheterization. The authors report on a 79-year-old who suffered coronary perforation and cardiac tamponade during elective stent implantation. Tamponade was successfully treated with pericardiocentesis and implantation of a membrane-covered graft stent. Subsequent recurrent pericarditis/postpericardial injury syndrome with moderate pericardial effusion was initially treated with aspirin and then with aspirin and colchicine. At 6 months, the patient is in stable remission even after withdrawal of colchicine. Conclusion: Natural history of pericardial diseases can be complicated with pericardial emergencies requiring prompt diagnosis, intensive care with hemodynamic monitoring, and early aggressive management. Medical supportive measures, drainage of pericardial effusion, surgical pericardiotomy, and pericardiectomy should be applied when needed with no delay. This procedural approach also applies to iatrogenic interventions leading to tamponade. © Urban & Vogel 2006.
